Göm menyn

Publications for Alf Kastbom

Co-author map based on Web of Sciences articles 2007-

Publications mentioned in social media 83 times*

Journal Articles

J. Stuemer, M. H. C. Biermann, J. Knopf, I. Magorivska, Alf Kastbom, A. Svärd, C. Janko, R. Bilyy, G. Schett, Christopher Sjöwall, M. Herrmann and L. E. Munoz
  Altered glycan accessibility on native immunoglobulin G complexes in early rheumatoid arthritis and its changes during therapy
  Clinical and Experimental Immunology, 2017, 189(3), 372-382.
 Web of Science® Times Cited: 3

Changrong Ge, Dongmei Tong, Bibo Liang, Erik Lönnblom, Nadine Schneider, Cecilia Hagert, Johan Viljanen, Burcu Ayoglu, Roma Stawikowska, Peter Nilsson, Gregg B Fields, Thomas Skogh, Alf Kastbom, Jan Kihlberg, Harald Burkhardt, Doreen Dobritzsch and Rikard Holmdahl
  Anti-citrullinated protein antibodies cause arthritis by cross-reactivity to joint cartilage
  JCI insight, 2017, 2(13), .

Michael Ziegelasch, Kristina Forslind, Thomas Skogh, Katrine Riklund, Alf Kastbom and Ewa Berglin
  Decrease in bone mineral density during three months after diagnosis of early rheumatoid arthritis measured by digital X-ray radiogrammetry predicts radiographic joint damage after one year
  Arthritis Research & Therapy, 2017, 19, .
   Fulltext  PDF  

Klara Martinsson, Anders Johansson, Alf Kastbom and Thomas Skogh
  Immunoglobulin (Ig)G1 and IgG4 anti-cyclic citrullinated peptide (CCP) associate with shared epitope, whereas IgG2 anti-CCP associates with smoking in patients with recent-onset rheumatoid arthritis (the Swedish TIRA project).
  Clinical and Experimental Immunology, 2017, 188(1), 53-62.
 Web of Science® Times Cited: 2

Michael Ziegelasch, Myrthe A M van Delft, Philip Wallin, Thomas Skogh, César Magro-Checa, Gerda M Steup-Beekman, Leendert A Trouw, Alf Kastbom and Christopher Sjöwall
  Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts.
  Arthritis Research & Therapy, 2016, 18(1), .
   Fulltext  PDF  
 Web of Science® Times Cited: 7

Alf Kastbom, Kristina Forslind, Sofia Ernestam, Pierre Geborek, Johan A. Karlsson, Ingemar F. Petersson, Saedis Saevarsdottir, Lars Klareskog, Ronald F. van Vollenhoven and Karin Lundberg
  Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial
  Annals of the Rheumatic Diseases, 2016, 75(2), 356-361.
   Fulltext  PDF  
 Web of Science® Times Cited: 9

Karin Roos, Klara Martinsson, Michael Ziegelasch, Yngve Sommarin, Anna Svärd, Thomas Skogh and Alf Kastbom
  Circulating secretory IgA antibodies against cyclic citrullinated peptides in early rheumatoid arthritis associate with inflammatory activity and smoking
  Arthritis Research & Therapy, 2016, 18(119), .
   Fulltext  PDF  
 Web of Science® Times Cited: 5

Sandra Hellberg, Daniel Eklund, Danuta Gawel, Mattias Köpsén, Huan Zhang, Colm Nestor, Ingrid Kockum, Tomas Olsson, Thomas Skogh, Alf Kastbom, Christopher Sjöwall, Magnus Vrethem, Irene Håkansson, Mikael Benson, Maria Jenmalm, Mika Gustafsson and Jan Ernerudh
  Dynamic Response Genes in CD4+T Cells Reveal a Network of Interactive Proteins that Classifies Disease Activity in Multiple Sclerosis
  Cell reports, 2016, 16(11), 2928-2939.
   Fulltext  PDF  
 Web of Science® Times Cited: 4

Charlotta Sandin, Per Eriksson, Mårten Segelmark, Thomas Skogh and Alf Kastbom
  IgA- and SIgA anti-PR3 antibodies in serum versus organ involvement and disease activity in PR3-ANCA associated vasculitis.
  Clinical and Experimental Immunology, 2016, 184(2), 208-215.
 Web of Science® Times Cited: 3

Anna Svärd, Thomas Skogh, Lars Alfredsson, Anna Ilar, Lars Klareskog, Camilla Bengtsson and Alf Kastbom
  Associations to smoking and shared epitope differ between IgA and IgG class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis
  Arthritis & Rheumatology, 2015, 67(8), 2032-2037.
 Web of Science® Times Cited: 15

Helena Enocsson, Christoffer Sjöwall, Lina Wirestam, Charlotte Dahle, Alf Kastbom, Johan Ronnelid, Jonas Wetterö and Thomas Skogh
  Four Anti-dsDNA Antibody Assays in Relation to Systemic Lupus Erythematosus Disease Specificity and Activity
  Journal of Rheumatology, 2015, 42(5), 817-825.
 Web of Science® Times Cited: 17

Alf Kastbom, Lisbeth Arlestig and Solbritt Rantapaa-Dahlqvist
  Genetic Variants of the NLRP3 Inflammasome Are Associated with Stroke in Patients with Rheumatoid Arthritis
  Journal of Rheumatology, 2015, 42(10), 1740-1745.
 Web of Science® Times Cited: 3

Helena Enocsson, Christopher Sjöwall, Alf Kastbom, Thomas Skogh, Maija-Leena Eloranta, Lars Rönnblom and Jonas Wetterö
  Association of Serum C-Reactive Protein Levels With Lupus Disease Activity in the Absence of Measurable Interferon-α and a C-Reactive Protein Gene Variant
  Arthritis & rheumatology (Hoboken, N.J.), 2014, 66(6), 1568-1573.
   Fulltext  PDF  
 Web of Science® Times Cited: 9

Martina Frodlund, Örjan Dahlström, Alf Kastbom, Thomas Skogh and Christopher Sjöwall
  Associations between antinuclear antibody staining patterns and clinical features of systemic lupus erythematosus: analysis of a regional Swedish register
  BMJ Open, 2013, 3, 1-8.
   Fulltext  PDF  
 Web of Science® Times Cited: 17

Alf Kastbom, E Klingberg, Deepti Verma, H Carlsten, H Forsblad-dElia, J Wesamaa, Jan Cedergren, Per Eriksson and P Söderkvist
  Genetic variants in CARD8 but not in NLRP3 are associated with ankylosing spondylitis
  Scandinavian Journal of Rheumatology, 2013, 42(6), 465-468.
 Web of Science® Times Cited: 12

Anna Svärd, Alf Kastbom, Yngve Sommarin and Thomas Skogh
  Salivary IgA antibodies to cyclic citrullinated peptides (CCP) in rheumatoid arthritis
  Immunobiology, 2013, 218(2), 232-237.
   Fulltext  PDF  
 Web of Science® Times Cited: 9

Anna Svärd, Alf Kastbom, Yngve Sommarin and Thomas Skogh
  A disease-modifying role for mucosal IgA antibodies to citrullinated antigens?
  Annals of the Rheumatic Diseases, 2012, 71(Issue suppl. 1), A38-A39.

Daniel Kanmert, Alf Kastbom, Gunnel Almroth, Thomas Skogh, Karin Enander and Jonas Wetterö
  IgG Rheumatoid Factors Against the Four Human Fc-gamma Subclasses in Early Rheumatoid Arthritis (The Swedish TIRA Project)
  Scandinavian Journal of Immunology, 2012, 75(1), 115-119.
   Fulltext  PDF  
 Web of Science® Times Cited: 3

Alf Kastbom, Lars Cöster, Lisbeth Ärlestig, Aikaterini Chatzidionysiou, Ronald F. van Vollenhoven, Leonid Padyukov, Solbritt Rantapää-Dahlqvist and Saedis Saevarsdottir
  Influence of FCGR3A genotype on the therapeutic response to rituximab in rheumatoid arthritis: an observational cohort study
  BMJ Open, 2012, 2(5), .
   Fulltext  PDF  
 Web of Science® Times Cited: 13

Anna Svärd, Alf Kastbom, Maria K. Söderlin, Åsa Reckner-Olsson and Thomas Skogh
  A Comparison Between IgG- and IgA-class Antibodies to Cyclic Citrullinated Peptides and to Modified Citrullinated Vimentin in Early Rheumatoid Arthritis and Very Early Arthritis
  Journal of Rheumatology, 2011, 38(7), 1265-1272.
 Web of Science® Times Cited: 22

Christoffer Sjöwall, Alf Kastbom, Gunnel Almroth, Jonas Wetterö and Thomas Skogh
  Beware of Antibodies to Dietary Proteins in "Antigen-specific" Immunoassays! Falsely Positive Anticytokine Antibody Tests Due to Reactivity with Bovine Serum Albumin in Rheumatoid Arthritis (The Swedish TIRA Project)
  JOURNAL OF RHEUMATOLOGY, 2011, 38(2), 215-220.
   Fulltext  PDF  
 Web of Science® Times Cited: 13

Alf Kastbom, Martin Johansson, Deepti Verma, Peter Söderkvist and Solbritt Rantapaa-Dahlqvist
  CARD8 p.C10X polymorphism is associated with inflammatory activity in early rheumatoid arthritis
  ANNALS OF THE RHEUMATIC DISEASES, 2010, 69(4), 723-726.
   Fulltext  PDF  
 Web of Science® Times Cited: 36

Daniel Kanmert, Helena Enocsson, Jonas Wetterö, Alf Kastbom, Thomas Skogh and Karin Enander
  Designed Surface with Tunable IgG Density as an in Vitro Model for Immune Complex Mediated Stimulation of Leukocytes
  Langmuir, 2010, 26(5), 3493-3497.
 Web of Science® Times Cited: 2

Marieke J H Coenen, Christian Enevold, Pilar Barrera, Mascha M V A P Schijvenaars, Erik J M Toonen, Hans Scheffer, Leonid Padyukov, Alf Kastbom, Lars Klareskog, Anne Barton, Wietske Kievit, Tim L Jansen, Dorine Swinkels, Piet L C M van Riel, Barbara Franke, Klaus Bendtzen and Timothy R D J Radstake
  Genetic Variants in Toll-Like Receptors Are Not Associated with Rheumatoid Arthritis Susceptibility or Anti-Tumour Necrosis Factor Treatment Outcome
  PLOS ONE, 2010, 5(12), .
   Fulltext  PDF  
 Web of Science® Times Cited: 20

Alf Kastbom, Deepti Verma, Per Eriksson, Thomas Skogh, Gun Wingren and Peter Söderkvist
  Genetic variation in proteins of the cryopyrin inflammasome influences susceptibility and severity of rheumatoid arthritis (the Swedish TIRA project)
  Rheumatology, 2008, 47(4), 415-417.
 Web of Science® Times Cited: 78

Anna Svärd, Alf Kastbom, Åsa Reckner Olsson and Thomas Skogh
  Presence and utility of IgA-class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis: the Swedish TIRA project
  Arthritis Research & Therapy, 2008, 10(4), .
 Web of Science® Times Cited: 31

Alf Kastbom, Johan Bratt, Sofia Ernestam, Jon Lampa, Leonid Padyukov, Peter Söderkvist and Thomas Skogh
  Fcγ receptor type IIIA genotype and response to tumor necrosis factor alpha-blocking agents in patients with rheumatoid arthritis
  Arthritis and Rheumatism, 2007, 56(2), 448-452.
 Web of Science® Times Cited: 49

Alf Kastbom, Ahmad Ahmadi, Peter Söderkvist and Thomas Skogh
  The 158V polymorphism of Fc gamma receptor type IIIA in early rheumatoid arthritis: increased susceptibility and severity in male patients (the Swedish TIRA project)
  Rheumatology, 2005, 44(10), 1294-1298.
 Web of Science® Times Cited: 40

Thomas Skogh, Alf Kastbom and Christoffer Sjöwall
  The B cells are back!
  Drug Discovery Today: Disease Mechanisms, 2005, 2(3), 351-357.

Maria Söderlin, Alf Kastbom, Hannu Kautiainen, Marjatta Leirisalo-Repo, Gunnar Strandberg and Thomas Skogh
  Antibodies against cyclic citrullinated peptide (CCP) and levels of cartilage oligomeric matrix protein (COMP) in very early arthritis: relation to diagnosis and disease activity
  Scandinavian Journal of Rheumatology, 2004, 33(3), 185-188.
 Web of Science® Times Cited: 42

Alf Kastbom, Gunnar Strandberg, Annette Lindroos and Thomas Skogh
  Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project)
  Annals of the Rheumatic Diseases, 2004, 63(9), 1085-1089.
 Web of Science® Times Cited: 237

Conference Articles

Anna Svärd, Alf Kastbom, Yngve Sommarin and Thomas Skogh
  A Disease-Modifying Role for Mucosal IgA Antibodies to Citrullinated Antigens? in ARTHRITIS AND RHEUMATISM, vol 63, issue 10, pp S849-S849

Maria Söderlin, Alf Kastbom, H Kautiainen, M Leirisalo-Repo, Gunnar Strandberg and Thomas Skogh
  Antibodies against cyclic citrullinated peptide (CCP) and cartilage oligomeric matrix protein (COMP) in relation to disease activity and erosions in a prospective population-based study of very early arthritis.
  Arthritis and Rheumatism, 2003.

 Web of Science® Times Cited: 1

Ph.D. Theses

Sudeep Chenna Narendra
  Systemic and local regulation of experimental arthritis by IFN-α, dendritic cells and uridine

  Fulltext PDF

Anna Svärd
  Circulating and Mucosal Antibodies to Citrullinated Antigens in Rheumatoid Arthritis

  Fulltext PDF

Alf Kastbom
  Autoantibodies and genetic variation in rheumatoid arthritis: aspects on susceptibility and disease course

  Fulltext PDF

* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.


Responsible for this page: Peter Berkesand
Last updated: 2010-08-30